Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Shares Outstanding (Weighted Average): 2009-2024

Historic Shares Outstanding (Weighted Average) for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $14.0 million.

  • Cumberland Pharmaceuticals' Shares Outstanding (Weighted Average) rose 6.13% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.0 million, marking a year-over-year increase of 6.13%. This contributed to the annual value of $14.0 million for FY2024, which is 1.50% down from last year.
  • Cumberland Pharmaceuticals' Shares Outstanding (Weighted Average) amounted to $14.0 million in FY2024, which was down 1.50% from $14.3 million recorded in FY2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Shares Outstanding (Weighted Average) peaked at $15.0 million during FY2020, and registered a low of $14.0 million during FY2024.
  • For the 3-year period, Cumberland Pharmaceuticals' Shares Outstanding (Weighted Average) averaged around $14.3 million, with its median value being $14.3 million (2023).
  • Data for Cumberland Pharmaceuticals' Shares Outstanding (Weighted Average) shows a maximum YoY decreased of 2.33% (in 2022) over the last 5 years.
  • Cumberland Pharmaceuticals' Shares Outstanding (Weighted Average) (Yearly) stood at $15.0 million in 2020, then declined by 1.51% to $14.8 million in 2021, then fell by 2.33% to $14.5 million in 2022, then fell by 1.44% to $14.3 million in 2023, then declined by 1.50% to $14.0 million in 2024.